We previously showed that 4H3MC inhibits T cell activation by targeting PKC and its downstream signaling pathways, but it does not trigger cell death [12]; therefore, we reasoned that 4H3MC may be used as an immunomodulator to limit AD because T cells make a significant contribution to the development and maintenance of this condition. The gene discussed is PRRT2; the disease is Alzheimer disease.